Clinical Trials on Human Papilloma Virus Infection Type 18 in China

Total 800 results

Xiamen University
Dongtai People's Hospital; Dongtai Center for Disease Control and Prevention; Dongtai Hospital of Traditional Chinese Medicine

Recruiting

Long-term Effectiveness of a Recombinant Hepatitis E Vaccine

Hepatitis E

China
Sinovac Biotech Co., Ltd

Completed

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

Seasonal Influenza

China
Sinovac Biotech Co., Ltd

Completed

A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

Seasonal Influenza

China
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise... and other collaborators

Completed

Clinical Trial of Recombinant Hepatitis E Vaccine

Hepatitis E

China
Sinovac Biotech Co., Ltd

Completed

The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine

Influenza

China
Capital Medical University

Recruiting

A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A

Influenza A

China
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection (VOYAGE-1)

Hepatitis C Virus (HCV)

China, Korea, Republic of, Singapore
Shanghai Changzheng Hospital

Unknown

Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis

Decompensated Cirrhosis | Hepatitis B Virus

China
Fujian Cosunter Pharmaceutical Co. Ltd

Completed

Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets

Hepatitis B

China
Johnson & Johnson Medical, China

Terminated

A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection

Hepatitis C

China
Gilead Sciences

Completed

Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection

Hepatitis C Virus Infection

Japan
Sclnow Biotechnology Co., Ltd.

Recruiting

hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis

Hepatitis B

China
Hospital Authority, Hong Kong

Completed

A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Neoplasms | Hepatitis B

China
Shanxi Medical University
Centers for Disease Control and Prevention, China

Not yet recruiting

Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Hepatitis B Vaccine

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Hepatitis B

China
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine

Influenza | Flu

China
Fujian Cosunter Pharmaceutical Co. Ltd

Unknown

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets

Hepatitis B

China
Beijing Center for Disease Control and Prevention

Completed

Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine

Healthy

China
Hospital Authority, Hong Kong
The University of Hong Kong

Unknown

A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

Hepatitis B

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Seasonal Influenza

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

Seasonal Influenza

China
Sun Yat-sen University

Unknown

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Recurrence | Hepatocellular Carcinoma | Hepatitis B Virus

China
Peking University People's Hospital
Bristol-Myers Squibb

Completed

HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China (HCV)

Hepatitis C

China
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

Influenza, Human

China
Beijing Ditan Hospital

Recruiting

Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy

Chronic Hepatitis B | COVID-19 Infection

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Prevention of Influenza

China
Beijing Municipal Science & Technology Commission

Unknown

Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination

Hepatitis B

China
Yuehua Huang

Completed

A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)

Hepatocellular Carcinoma

China
Capital Medical University

Unknown

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study

Influenza

China
Hoffmann-La Roche

Terminated

Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients

Hepatitis B, Chronic

China
First Affiliated Hospital Xi'an Jiaotong University

Unknown

Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy

Hepatitis B, Chronic

China
Ying-Jie Ji

Completed

Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B

Hepatitis B, Chronic

China
Eastern Hepatobiliary Surgery Hospital

Completed

Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC (TACEPVE)

Hepatocellular Carcinoma

China
Huazhong University of Science and Technology
The University of Queensland

Completed

Effect of Selenium Supplementation on Influenza Vaccination

Influenza Vaccination | Selenium Supplementation

China
Changchun BCHT Biotechnology Co.
He Bei province Center for Disease control and prevention

Recruiting

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Influenza Prevention

China
The University of Hong Kong

Completed

Convalescent Plasma Treatment in Severe 2009 H1N1 Infection

Influenza A

China
Gilead Sciences

Completed

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis

Hepatitis C Virus Infection

Japan
Peking University

Unknown

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

Hepatitis B

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age

Influenza

China
Beijing Center for Disease Control and Prevention

Completed

Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza

Influenza

China
Jun Zhang
Xiamen Innovax Biotech Co., Ltd; Xiamen Center for Disease Control and Prevention

Completed

Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

Hepatitis E

China
Jiangsu Province Centers for Disease Control and...
Changchun Institute of Biological Products Co., Ltd.

Completed

A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults

Hepatitis E

China
Hutchison Whampoa Guangzhou Baiyunshan Chinese...
Guangzhou Institute of Respiratory Disease

Unknown

Banlangen Granules Anti-seasonal Influenza Study (BLG)

Influenza

China
Beijing 302 Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown

Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

Hepatocellular Carcinoma

China
Novartis

Completed

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

Hepatitis B, Chronic

China
Changhai Hospital

Completed

Optimization of Antiviral Therapy of Chronic HBV Infection

Hepatitis B | Adverse Effects | Australia Antigen Positive

China
Children's Hospital of Chongqing Medical University

Recruiting

Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing

Hepatitis B Vaccine Adverse Reaction

China
Hui Zhuang
Guangxi Center for Disease Control and Prevention

Completed

Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students

Immune Response | Hepatitis B | Seroprevalence

China
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

Neutrino Regimen for Treatment-experienced HCV GT1 Patients

Chronic Hepatitis C Infection

China

3

Subscribe